Tirzepatide
Discover the most effective weight loss tool on the market. People using Tirzepatide lose more weight than any other GLP-1 product. Tirzepatide patients lose on average 22.5% of body weight in 72 weeks.
- Starting at $399 Monthly Weight Loss Protocol
-
Free priority shipping
-
Access to doctor in 24h
-
Board-certified doctors
IN STOCK
SCIENCE-BACKED BENEFITS
- Feel full faster and longer GLP-1 agonists act on an area in the brain that regulates appetite. They make you feel full and satisfied, which reduces the amount you eat. 1
- Lose up to 22.5% of your body weight Studies show that individuals using tirzepatide lost on average 22.5% of their body weight over a 72 week period, more than any other GLP-1 agonist. 2
- Increased insulin sensitivity Tirzepatide helps regulate your glucose, or blood sugar, levels meaning you reduce your risk for Type 2 diabetes. 3
Understanding the Science
Ingredient
Tirzepatide
How it works
Tirzepatide is a dual GIP and GLP-1 receptor agonist. This means, in addition to mimicking the effects of GLP-1, it also mimics the effects of the GIP (glucose-dependent insulinotropic polypeptide) hormone. The combined action on both receptors provides additional benefits for weight loss.
Sustained weight loss
GLP-1s work on key underlying metabolic pathways to support sustained weight loss, rather than a quick fix. You'll lose the weight, and keep it off.
Drug Facts
Frequency:
1 weekly shot
Application:
Subcutaneous Injection
Tirzepatide
2.5mg - 15mg
When a medication is used in a manner that differs from the specific uses approved by the FDA, it is referred to as "off-label" prescribing. This means the medication is being employed for conditions, dosages, or patient groups not explicitly stated in the FDA's official approval.
Typically, after the FDA sanctions a drug, it specifies the particular medical conditions for which the drug is deemed effective on its label.
However, medical professionals have the discretion to prescribe these drugs for purposes beyond the scope of the FDA’s approval, provided they believe it to be beneficial and suitable for the patient's specific medical needs.
Prescription Based
Unlike over-the-counter medications, GLP-1s are doctor prescribed. This means they're trusted by medical experts to help you lose weight.
Lose Weight Quickly
GLP-1 medications like tirzepatide have demonstrated weight loss on average 22.5% of body weight in approximately a year.
All science, none of the B.S.
Customized prescription
Weight loss is not a one-size-fits-all problem. Get prescribed your custom dosage and adjust on a monthly basis with a board certified physician.
Real results
Unlike fad diets or over-the-counter weight loss pills, tirzepatide has shown significant weight loss results across a variety of studies. 2
Subcutaneous injection
A weekly self-administered administered injection that causes reduced appetite and leads to weight loss.
Tirzepatide for Weight Loss
Stimulate your body’s natural blood hormones to reduce appetite, feel full longer, and lose weight quickly.
Starting at $399.99/mo
Our tirzepatide solution offers tailor-made weight loss prescriptions based on your personal anatomy, using licensed physicians, all from your phone.
Get StartedIN STOCK
You have questions, we have answers.
Contact supportHow Does “Tirzepatide” Contribute to Weight Management? ‘Tirzepatide’ is designed to assist in weight management through a variety of mechanisms. It is intended to help regulate insulin production in response to changes in blood sugar levels, potentially aiding in maintaining balanced blood sugar. Additionally, it focuses on the aspect of managing food intake and the rate at which food moves through the digestive system. These factors are aimed at helping to extend the feeling of fullness and potentially influencing the amount of food consumed.
The response time for “Tirzepatide” may differ for each individual. This product is designed to support weight management efforts, potentially by influencing blood sugar levels. It may take about 8-12 weeks to observe progress towards a targeted A1C goal. The dosage of “Tirzepatide” is adjusted gradually under medical supervision to determine the most effective amount for each person, a process that can extend over several weeks or months for full observation of its effects on blood sugar levels.
When considering “Tirzepatide” for weight loss, it’s important to understand the potential timeframe for results. According to available data:
-
Participants on a placebo experienced an average weight loss of 3.7%.
-
Those taking 5mg of “Tirzepatide with B6” achieved an average weight loss of 15%.
-
The weight loss further increased to 19% for individuals on a 10mg dosage of “Tirzepatide with B6”. This suggests that a 200-lb individual might anticipate shedding nearly 40 lbs.
Notably, initial effects may become noticeable within 1-2 weeks of starting the regimen. However, individual responses can vary, and it’s essential to consult with a healthcare professional to determine the most suitable approach for weight management.
“Tirzepatide” operates through a novel mechanism of action, primarily targeting the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. By activating these receptors, it facilitates better regulation of blood sugar levels.
Administered via a subcutaneous injection, typically once weekly, “Tirzepatide” offers a convenient and pain-free method of delivery. This dual receptor activation distinguishes it as a first-in-class medication for managing blood sugar levels.
“Tirzepatide” and Ozempic® differ in their mechanism of action. “Tirzepatide” acts on both the GIP and GLP-1 receptors, whereas Ozempic® solely targets the GLP-1 receptor. This distinction in receptor activation may lead to differences in their efficacy and side effect profiles.
The most common side effects of “Tirzepatide” include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of “Tirzepatide”. Talk to your healthcare provider about any side effects that bother you or do not go away.”
Using “Tirzepatide” in combination with an insulin secretagogue (such as a sulfonylurea) or insulin may heighten the risk of hypoglycemia, including severe cases. Its compatibility with individuals who have experienced pancreatitis remains uncertain. Additionally, “Tirzepatide” is not indicated for individuals with type 1 diabetes, and its safety and efficacy in those under 18 years old have not been determined.”
We hold ourselves to the highest scientific standards — here are our sources.
| 1 |
GLP-1 agonists act on an area in the brain that regulates appetite. They make you feel full and satisfied, which reduces the amount you eat. |
CS Marathe CS et al. Exp Diabetes Res. 2011 |
| 2 |
Studies show that individuals using tirzepatide on average 22.5% of their body weight over a 72 week period, more than any other GLP-1 agonist |
A Jastreboff et all. N Engl J Med 2022 |
| 3 |
Tirzepatide helps regulate your glucose, or blood sugar, levels meaning you reduce your risk for Type 2 diabetes. |
M Nauck et all.Cardiovascular Diabetology. 2022 |
| 4 |
The annual probability of attaining normal weight was 1-in-210 for obese men. |
Fildes A et al. Am J Public Health. 2015. |
| 5 |
83% of people fail their weight loss diets. |
Mann T et al. Am Psychol. 2007. |
| 6 |
Trials have seen a reduction of up to 19.3% in body fat. |
Wilding JP et al. J Endocr Soc. 2021 |
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
